NCT06136650 · Interventional trial
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Overall registry status Recruiting
Phase 3
Conditions Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostatic Neoplasms
Delaware Valley sites
- Fox Chase Cancer Center ( Site 0076) · Philadelphia, PA · Philadelphia County · Recruiting
- MidLantic urology ( Site 0022) · Bala-Cynwyd, PA · Montgomery County · Recruiting
First posted
Registry updated
Added to the directory